Cetera Investment Advisers
VRNA

Cetera Investment Advisers’s Verona Pharma VRNA Stock Holding History

Cetera Investment Advisers’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,766
Closed -$1.47M – 4877
2025
Q3 		$1.47M Sell
13,766
-10,893
-44% -$1.14M ﹤0.01% 2435
2025
Q2 		$2.33M Sell
24,659
-59
-0.2% -$4.37K ﹤0.01% 1729
2025
Q1 		$1.57M Buy
24,718
+1,453
+6% +$86.9K ﹤0.01% 1932
2024
Q4 		$1.08M Buy
23,265
+12,362
+113% +$464K ﹤0.01% 2114
2024
Q3 		$314K Buy
+10,903
New +$268K ﹤0.01% 3029

Other funds holding VRNA

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Cetera Investment Advisers's VRNA Position: Q4 2025 in Review

Cetera Investment Advisers sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 13,766 shares — an estimated $1.47M sold.

Cetera Investment Advisers first reported a position in VRNA in Q3 2024 and held it in 5 quarters. The position peaked at $2.33M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

  • Cetera Investment Advisers reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
  • Cetera Investment Advisers sold 13,766 Verona Pharma shares in Q4 2025, an estimated $1.47M.
  • Cetera Investment Advisers first reported a position in Verona Pharma in Q3 2024 and held it in 5 quarters.
  • Cetera Investment Advisers's Verona Pharma position peaked at $2.33M in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Cetera Investment Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.